- Report
- January 2022
- 200 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- October 2022
- 39 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- November 2020
- 45 Pages
Global
From €1930EUR$2,000USD£1,656GBP
Rubella is a viral infection caused by the rubella virus. It is typically mild and can be treated with rest and fluids. Infectious Diseases Drugs are used to treat and prevent the spread of infectious diseases, including rubella. These drugs can be used to reduce the severity of symptoms, prevent complications, and reduce the risk of transmission.
The Rubella Drug market is composed of a variety of drugs used to treat and prevent the spread of rubella. These drugs include antiviral medications, immunoglobulins, and vaccines. Antiviral medications are used to reduce the severity of symptoms and prevent complications. Immunoglobulins are used to boost the body's immune response to the virus. Vaccines are used to prevent the spread of the virus.
Some companies in the Rubella Drug market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more